CliffBio
small molecule

TOPOTECAN HYDROCHLORIDE

TOPOTECAN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameTOPOTECAN HYDROCHLORIDE
Active ingredientTOPOTECAN HYDROCHLORIDE
StrengthEQ 4MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2010
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.